相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma
Shin Hamada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
Kathryn C. Arbour et al.
CLINICAL CANCER RESEARCH (2018)
Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
Youngtae Jeong et al.
CANCER DISCOVERY (2017)
Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
Kouhei Tsuchida et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice
Takuma Suzuki et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
NRF2 Activation Impairs Quiescence and Bone Marrow Reconstitution Capacity of Hematopoietic Stem Cells
Shohei Murakami et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model
H. Kitamura et al.
ONCOGENE (2017)
Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus
Takafumi Suzuki et al.
NATURE COMMUNICATIONS (2017)
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma
Federico Pio Fabrizio et al.
ONCOTARGET (2017)
Enhanced Degradation of Misfolded Proteins Promotes Tumorigenesis
Liang Chen et al.
CELL REPORTS (2017)
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Z. Fan et al.
ONCOGENESIS (2017)
Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas
Jelena Todoric et al.
CANCER CELL (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding
Wenjie Ge et al.
CANCER CELL (2017)
NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth
Hironori Satoh et al.
CANCER RESEARCH (2016)
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Iok In Christine Chio et al.
CELL (2016)
Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
Evan C. Lien et al.
NATURE CELL BIOLOGY (2016)
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Eri H. Kobayashi et al.
NATURE COMMUNICATIONS (2016)
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
Clarissa Ribeiro Reily Rocha et al.
ONCOTARGET (2016)
Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
Leonard D. Goldstein et al.
CELL REPORTS (2016)
Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma
Jiang Chen et al.
CANCER MEDICINE (2016)
NRF2 Is a Key Target for Prevention of Noise-Induced Hearing Loss by Reducing Oxidative Damage of Cochlea
Yohei Honkura et al.
SCIENTIFIC REPORTS (2016)
Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas
Wen-Chiuan Tsai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer
Yota Kawasaki et al.
BMC CANCER (2015)
Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma
Mingxin Zhang et al.
BMC CANCER (2015)
TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
Naoki Oshimori et al.
CELL (2015)
Keap1 expression has independent prognostic value in pancreatic adenocarcinomas
Joel Isohookana et al.
DIAGNOSTIC PATHOLOGY (2015)
Impact of nuclear factor erythroid-derived 2-like 2 and p62/sequestosome expression on prognosis of patients with gliomas
Mingfei Zhao et al.
HUMAN PATHOLOGY (2015)
NRF2 regulates serine biosynthesis in non-small cell lung cancer
Gina M. DeNicola et al.
NATURE GENETICS (2015)
Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer
Victor D. Martinez et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients
Masayuki Kanamori et al.
NEURO-ONCOLOGY (2015)
Functional Role of NRF2 in Cervical Carcinogenesis
Jun-Qi Ma et al.
PLOS ONE (2015)
Nrf2 is Useful for Predicting the Effect of Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma
Yota Kawasaki et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Myeloid Lineage-Specific Deletion of Antioxidant System Enhances Tumor Metastasis
Keiichiro Hiramoto et al.
CANCER PREVENTION RESEARCH (2014)
Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
Shasha Tao et al.
CANCER RESEARCH (2014)
NRF2 immunolocalization in human breast cancer patients as a prognostic factor
Yoshiaki Onodera et al.
ENDOCRINE-RELATED CANCER (2014)
NF-E2-Related Factor 2 Promotes Compensatory Liver Hypertrophy After Portal Vein Branch Ligation in Mice
Keiichi Shirasaki et al.
HEPATOLOGY (2014)
Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers
Keiko Taguchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Kinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1
Toshiaki Fukutomi et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma
Y. Soini et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer
Annette Hayden et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Nrf2 Overexpression Predicts Prognosis and 5-FU Resistance in Gastric Cancer
Xiu-Feng Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Nrf2 is required to maintain the self-renewal of glioma stem cells
Jianhong Zhu et al.
BMC CANCER (2013)
Nrf2 Prevents Initiation but Accelerates Progression through the Kras Signaling Pathway during Lung Carcinogenesis
Hironori Satoh et al.
CANCER RESEARCH (2013)
Regulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels
Takafumi Suzuki et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy
Yoshinobu Ichimura et al.
MOLECULAR CELL (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
S. Chowdhry et al.
ONCOGENE (2013)
Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model
Xiang-Jun Ji et al.
ONCOLOGY REPORTS (2013)
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Yoichiro Mitsuishi et al.
CANCER CELL (2012)
Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma
Daisuke Inoue et al.
CANCER SCIENCE (2012)
An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma
Aikseng Ooi et al.
CANCER CELL (2011)
Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
Julie Adam et al.
CANCER CELL (2011)
Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
CANCER RESEARCH (2011)
Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
Yoshihiro Inami et al.
JOURNAL OF CELL BIOLOGY (2011)
SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
Patricia Rada et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
NRF2 Mutation Confers Malignant Potential and Resistance to Chemoradiation Therapy in Advanced Esophageal Squamous Cancer
Tatsuhiro Shibata et al.
NEOPLASIA (2011)
Global Downstream Pathway Analysis Reveals a Dependence of Oncogenic NF-E2-Related Factor 2 Mutation on the mTOR Growth Signaling Pathway
Tatsuhiro Shibata et al.
CANCER RESEARCH (2010)
Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
Hironori Satoh et al.
CARCINOGENESIS (2010)
Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features
Luisa M. Solis et al.
CLINICAL CANCER RESEARCH (2010)
Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1
Keiko Taguchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
Ping Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains
Toshihiko Ogura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
Tatsuhiro Shibata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Different electrostatic Potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response
Kit I. Tong et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Keap1 recruits Neh2 through binding to ETGE and DLG motifs: Characterization of the two-site molecular recognition model
KI Tong et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
B Padmanabhan et al.
MOLECULAR CELL (2006)
Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity
H Okawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
K Iida et al.
CANCER RESEARCH (2004)
Nrf2-Keap1 defines a physiologically important stress response mechanism
H Motohashi et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
N Wakabayashi et al.
NATURE GENETICS (2003)
Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice
M Ramos-Gomez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes
A Enomoto et al.
TOXICOLOGICAL SCIENCES (2001)
分享论文
